ODT Odonate Therapeutics, Inc. gains 29% Jan 19, 2021

Posted By: Rajesh Srivastava - Tuesday, January 19, 2021

Share

& Comment

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer; and CONTESSA 2 and CONTESSA TRIO, which is in Phase II clinical study for central nervous system metastases and various cancer treatments. The company was founded in 2013 and is based in San Diego, California.http://www.priceseries.com/trade/ODT-Odonate-Therapeutics-Inc-stock-gains-29-percent-a-Trade-Record-by-priceSeries-2020122220210119.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © 2025 priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.